Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115950) titled 'Clinical Study of ctDNA Dynamic Monitoring in Sacituzumab tirumotecan for EGFR-Mutated Non-Squamous NSCLC After EGFR-TKI Failure' on Jan. 4.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shaanxi Provincial Cancer Hospital
Condition:
NSCLC
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-05
Target Sample Size: Experimental group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=296050
Published by HT Digital Content Services with permission from Health Daily Digest....